Clarithromycin
Active ingredient: Clarithromycin
In short: Clarithromycin tablets, USP are indicated in adults for the treatment of mild to moderate infections caused by susceptible isolates due to Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, or Streptococcus pneumoniae . Clarithromycin tablets, USP are indicated for the treatm
What is Clarithromycin used for?
Clarithromycin tablets, USP are indicated in adults for the treatment of mild to moderate infections caused by susceptible isolates due to
Haemophilus influenzae,
Haemophilus parainfluenzae,
Moraxella catarrhalis, or
Streptococcus pneumoniae
.
Clarithromycin tablets, USP are indicated for the treatment of mild to moderate infections caused by susceptible isolates due to
Haemophilus influenzae,
Moraxella catarrhalis, or
Streptococcus pneumoniae
.
Clarithromycin tablets, USP are indicated
for the treatment of mild to moderate infections caused by susceptible isolates due to:
Haemophilus influenzae(in adults)
Mycoplasma pneumoniae,
Streptococcus pneumoniae,
Chlamydophila pneumoniae
Clarithromycin tablets, USP are indicated for the treatment of mild to moderate infections caused by susceptible isolates due to
Streptococcus pyogenesas an alternative in individuals who cannot use first line therapy.
Clarithromycin tablets, USP are indicated for the treatment of mild to moderate infections caused by susceptible isolates due to
Staphylococcus aureus, or
Streptococcus pyogenes.
Clarithromycin tablets, USP are indicated in pediatric patients for the treatment of mild to moderate infections caused by susceptible isolates due to
Haemophilus influenzae,
Moraxella catarrhalis, or
Streptococcus pneumoniae
. …
Clarithromycin dosage
Clarithromycin tablets may be given with or without food.
The recommended dosages of clarithromycin for the treatment of mild to moderate infections in adults are listed in Table 1.
Clarithromycin tablets
Infection | Dosage
(every 12 hours) | Duration
(days)
Acute bacterial exacerbation of chronic bronchitis | 250 to 500 mg
a | 7
b-14
Acute maxillary sinusitis | 500 mg | 14
Community-acquired pneumonia | 250 mg
c | 7
d-14
Pharyngitis/Tonsillitis | 250 mg | 10
Uncomplicated skin and skin structure infections | 250 mg | 7-14
Treatment and prophylaxis of disseminated
Mycobacterium aviumdisease
| 500 mg
e | -
H.pylorieradication to reduce the risk of duodenal ulcer recurrence with amoxicillin and omeprazole or lansoprazole
| 500 mg | 10-14
H.pylorieradication to reduce the risk of duodenal ulcer recurrence with omeprazole
| 500 mg every 8 hours | 14
aFor
M. catarrhalisand
S. pneumoniaeuse 250 mg. For
H. influenzaeand
H. parainfluenzae, use 500 mg.
bFor
H. parainfluenzae, the duration of therapy is 7 days.
cFor
H. parainfluenzaeand
M. catarrhalisuse clarithromycin extended-release tablets only.
dFor
H. influenzae, the duration of therapy is 7 days.
eClarithromycin therapy should continue if clinical response is observed. Clarithromycin can be discontinued when the patient is considered at low risk of disseminated infection.
Triple therapy: clarithromycin/lansoprazole/amoxicillin
The recommended adult dosage is 500 mg clarithromycin, 30 mg lansoprazole, and 1 gram amoxicillin, all given every 12 hours for 10 or 14 days
.
Triple therapy: clarithromycin/omeprazole/amoxicillin
The recommended adult dosage is 500 mg clarithromycin, 20 mg omeprazole, and 1 gram amoxicillin; all given every 12 hours for 10 days. In patients with an ulcer present at the time of initiation of therapy, an additional 18 days of omeprazole 20 mg once daily is recommended for ulcer healing and symptom relief
.
Dual therapy: clarithromycin/omeprazole
The recommended adult dosage is 500 mg clarithromycin given every 8 hours and 40 mg omeprazole given once every morning for 14 days. An additional 14 days of omeprazole 20 mg once daily is recommended for ulcer healing and symptom relief
.
The recommended daily dosage is 15 mg/kg/day divided every 12 hours for 10 days (up to the adult dose). Refer to dosage regimens for mycobacterial infections in pediatric patients for additional dosage information
.
For the treatment of disseminated infection due to
Mycobacterium aviumcomplex (MAC), clarithromycin is recommended as the primary agents. Clarithromycin should be used in combination with other antimycobacterial drugs (e.g., ethambutol) that have shown
in vitroactivity against MAC or clinical benefit in MAC treatment
. …
How to take Clarithromycin — instructions & advice from the label
Provide the following instructions or information about clarithromycin tablets to patients:
Important Administration Instructions
Advise patients that clarithromycin tablets can be taken with or without food and can be taken with milk.
Drug Interactions
Advise patients that clarithromycin may interact with some drugs; therefore, advise patients to report to their healthcare provider the use of any other medications.
Diarrhea
Advise patients that diarrhea is a common problem caused by antibacterials including clarithromycin which usually ends when the antibacterial is discontinued. Sometimes after starting treatment with antibacterials, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibacterial. If this occurs, instruct patients to contact their healthcare provider as soon as possible.
Embryo-Fetal Toxicity
Advise females of reproductive potential that that if pregnancy occurs while taking this drug, there is a potential hazard to the fetus
. …
Warnings & precautions
Do not take this medicine if: Clarithromycin is contraindicated in patients with a known hypersensitivity to clarithromycin, erythromycin, or any of the macrolide antibacterial drugs
.
Concomitant administration of clarithromycin with cisapride and pimozide is contraindicated
.
There have been postmarketing reports of drug interactions when clarithromycin is co-administered with cisapride or pimozide, resulting in cardiac arrhythmias (QT prolongation, ventricular tachycardia, ventricular fibrillation, and
torsades de pointes) most likely due to inhibition of metabolism of these drugs by clarithromycin. Fatalities have been reported.
Clarithromycin is contraindicated in patients with a history of cholestatic jaundice or hepatic dysfunction associated with prior use of clarithromycin.
Concomitant administration of clarithromycin and colchicine is contraindicated in patients with renal or hepatic impairment.
Concomitant administration of clarithromycin with lomitapide is contraindicated due to potential for markedly increased transaminases
.
Concomitant administration of clarithromycin with HMG-CoA reductase inhibitors (statins) that are extensively metabolized by CYP3A4 (lovastatin or simvastatin) is contraindicated, due to the increased risk of myopathy, including rhabdomyolysis
.
Concomitant administration of clarithromycin and ergotamine or dihydroergotamine is contraindicated
.
Concomitant administration of clarithromycin and lurasidone is contraindicated since it may result in an increase in lurasidone exposure and the potential for serious adverse reactions
.
For information about contraindications of other drugs indicated in combination with clarithromycin, refer to their full prescribing information (contraindications section). …
Clarithromycin side effects
The following serious adverse reactions are described below and elsewhere in the labeling:
Acute Hypersensitivity Reactions
QT Prolongation
Hepatotoxicity
Serious Adverse Reactions Due to Concomitant Use with Other Drugs
Clostridium difficileAssociated Diarrhea
Exacerbation of Myasthenia Gravis
Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.
Based on pooled data across all indications, the most frequent adverse reactions for both adult and pediatric populations observed in clinical trials are abdominal pain, diarrhea, nausea, vomiting and dysgeusia. Also reported were dyspepsia, liver function test abnormal, anaphylactic reaction, candidiasis, headache, insomnia, and rash.
The subsequent subsections list the most common adverse reactions for prophylaxis and treatment of mycobacterial infections and duodenal ulcer associated with
H. pyloriinfection. In general, these profiles are consistent with the pooled data described above.
Prophylaxis of Mycobacterial Infections
In AIDS patients treated with clarithromycin over long periods of time for prophylaxis against
M. avium, it was often difficult to distinguish adverse reactions possibly associated with clarithromycin administration from underlying HIV disease or intercurrent illness. …
Drug interactions
Co-administration of clarithromycin is known to inhibit CYP3A, and a drug primarily metabolized by CYP3A may be associated with elevations in drug concentrations that could increase or prolong both therapeutic and adverse effects of the concomitant drug.
Clarithromycin should be used with caution in patients receiving treatment with other drugs known to be CYP3A enzyme substrates, especially if the CYP3A substrate has a narrow safety margin (e.g., carbamazepine) and/or the substrate is extensively metabolized by this enzyme. Adjust dosage when appropriate and monitor serum concentrations of drugs primarily metabolized by CYP3A closely in patients concurrently receiving clarithromycin.
Drugs That Are Affected By Clarithromycin
Drug(s) with Pharmacokinetics Affected by Clarithromycin | Recommendation | Comments
Antiarrhythmics:
Disopyramide
Quinidine
Dofetilide
Amiodarone
Sotalol
Procainamide | Not Recommended | Disopyramide, Quinidine:There have been postmarketing reports of
torsades de pointesoccurring with concurrent use of clarithromycin and quinidine or disopyramide. Electrocardiograms should be monitored for QTc prolongation during coadministration of clarithromycin with these drugs
.
Serum concentrations of these medications should also be monitored. …
About this medicine
Clarithromycin is a semi-synthetic macrolide antimicrobial for oral use. Chemically, it is 6-
0-methylerythromycin. The molecular formula is C
38H
69NO
13, and the molecular weight is 747.96. The structural formula is:
Figure 1: Structure of Clarithromycin
Clarithromycin is a white to off-white crystalline powder. It is soluble in acetone, slightly soluble in methanol, ethanol, and acetonitrile, and practically insoluble in water.
Each white to off-white oval film-coated immediate-release clarithromycin tablet, USP contains 250 mg or 500 mg of clarithromycin and the following inactive ingredients: croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone, silicon dioxide, hypromellose, titanium dioxide and polyethylene glycol.
How it works: Clarithromycin is a macrolide antimicrobial drug . Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%. For a single 500 mg dose of clarithromycin, food slightly delays the onset of clarithromycin absorption, increasing the peak time from approximately 2 to 2.5 hours.
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 1cb8a78a-0f07-49e8-a23e-a77628006209. Read the full official label on DailyMed.
Related medicines
Amoxicillin Azithromycin Doxycycline Amoxicillin and Clavulanate Cephalexin Valacyclovir Sulfamethoxazole and Trimethoprim Nitrofurantoin